Advancements in the Management of Ovarian Cancer - Episode 1
Panelists discuss how biomarker testing for advanced ovarian cancer, including when and which biomarkers to test (such as HRD), plays a crucial role in guiding treatment decisions and personalizing patient care.
Video content above is prompted by the following: